Amanote Research
Register
Sign In
Factor Xa Inhibitors
doi 10.1007/978-3-319-25460-9_3
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2016
Authors
Eduard Shantsila
Gregory YH Lip
Publisher
Springer International Publishing
Related search
Engineered Factor Xa Variants Retain Procoagulant Activity Independent of Direct Factor Xa Inhibitors
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?
Clinical Orthopaedics and Related Research
Medicine
Surgery
Orthopedics
Sports Medicine
Sports Science
Safety of 4-Factor Prothrombin Complex Concentrate (4f-Pcc) for Emergent Reversal of Factor Xa Inhibitors
Journal of Intensive Care
Critical Care
Intensive Care Medicine
Phosphatidylserine and Factor VA Regulate Factor Xa Structure
Biophysical Journal
Biophysics
Discovery of a Novel, Potent, and Specific Family of Factor Xa Inhibitors via Combinatorial Chemistry
Biochemistry
Biochemistry
Current Status and Future of Anti-Xa Inhibitors
Clinical Neurology
Neurology
Erratum To: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
Thrombosis and Haemostasis
Hematology
Antithrombin-Independent Thrombin Inhibitors, but Not Direct Factor Xa Inhibitors, Enhance Thrombin Generation in Plasma Through Inhibition of Thrombin-Thrombomodulin-Protein C System
Thrombosis and Haemostasis
Hematology
Antithrombotic Drug and Its Clinical Indication. Factor Xa Inhibitor. Oral Xa Inhibitor (DX-9065a).
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
